- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02873572
Vulnerability Markers in Pathological Gambling (GambleMMORe)
Marqueurs de vulnérabilité Aux Jeux Pathologiques
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Besancon, France, 25000
- Recruiting
- CHU Besancon
-
Sub-Investigator:
- Julie Giustiniani, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- arm 1: online poker gamblers who don't play another type of gamble/game
- arm 2: casino gamblers who don't play another type of gamble/game
- arm 3: MMORPG gamers who don't play another type of gamble/game
- arm 4: no-gamblers/gamers subjects
- step 2 : only right-handled subjects (due to registration of brain activity)
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: online poker gamblers
Recruitment by forums of online poker gamblers: an explanation of the research is sent with the dedicated link of the research.
|
Anonymous psychiatric and behavioral assessments to evaluate in particular addiction or pathological gambling/gaming and behavioral profile of gamblers/gamers.
Once questionnaire completed, if the subjects want to continue to participate, they sent their email to investigators.
For each arm, subjects were divided into 2 groups: dependant or not dependant gamblers/gamers. Investigators focused on decision-making biomarkers following the following flow-chart:
|
|
Experimental: casino gamblers
Recruitment to the casino gates: an explanation of the research is sent with the dedicated e-link of the research and they could answer directly to the questionnaire (1st step) on sites.
|
Anonymous psychiatric and behavioral assessments to evaluate in particular addiction or pathological gambling/gaming and behavioral profile of gamblers/gamers.
Once questionnaire completed, if the subjects want to continue to participate, they sent their email to investigators.
For each arm, subjects were divided into 2 groups: dependant or not dependant gamblers/gamers. Investigators focused on decision-making biomarkers following the following flow-chart:
|
|
Experimental: MMORPG gamers
Recruitment by forums of MMORPG (as guilds): an explanation of the research is sent with the dedicated link of the research.
|
Anonymous psychiatric and behavioral assessments to evaluate in particular addiction or pathological gambling/gaming and behavioral profile of gamblers/gamers.
Once questionnaire completed, if the subjects want to continue to participate, they sent their email to investigators.
For each arm, subjects were divided into 2 groups: dependant or not dependant gamblers/gamers. Investigators focused on decision-making biomarkers following the following flow-chart:
|
|
Experimental: no gamer subjects
Recruitment by poster.
|
Anonymous psychiatric and behavioral assessments to evaluate in particular addiction or pathological gambling/gaming and behavioral profile of gamblers/gamers.
Once questionnaire completed, if the subjects want to continue to participate, they sent their email to investigators.
For each arm, subjects were divided into 2 groups: dependant or not dependant gamblers/gamers. Investigators focused on decision-making biomarkers following the following flow-chart:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Compare the average activation differences in each arm regarding the dependance level and between the 4 arms.
Time Frame: up to 4 weeks
|
up to 4 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Philip Gorwood, MD PhD, Saint Anne's Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- N/2009/54
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.